Dr. Cintia Citterio has been honored as a recipient of the 2024 American Association of Colleges of Pharmacy (AACP) New Investigator Award (NIA) for her proposal “Molecular Pathogenesis of Thyroid Cystinosis and New Therapeutic Approaches.” The AACP NIA is a highly competitive achievement that offers $11,000 to exceptional early-career pharmacy faculty members, placing Dr. Citterio
Not even 30 years old, Dr. Judy Weng has accomplished what only few could dream of- two doctorate degrees, an incredible CV of research and teaching, and a career lined up that balances her passions and her childhood dream. “If I were to do it all over again, I would choose Chapman,” she says. “Being
Publications Dr. Keykavous Parang collaborated to produce “Harnessing exosomes as a platform for drug delivery in breast cancer: A Systematic review for in vivo and in vitro studies” in Molecular Therapy Oncology. Dr. Jelena Lewis and PharmD candidate Brenda Kilzi authored “Respiratory syncytial virus (RSV)—Who is at risk, and who can be vaccinated?” in Topics
Since graduating with his Doctor of Pharmacy in 2019, Dr. John Andraos has merged his passions for teaching and patient care. Currently serving as an Assistant Professor at Western University College of Pharmacy, Dr. Andraos was part of the inaugural APEx program before bridging into CUSP for his Doctor of Pharmacy degree. Dr. Andraos initially
Chapman University students, faculty, and alumni turned up in record numbers at the 2024 Western Pharmacy Exchange, hosted by the California Pharmacists Association (CPhA) in Las Vegas from April 19-21. CPhA honored Dr. Laressa Bethishou with the 2024 New Practitioner Award, which recognizes an outstanding new practitioner who has demonstrated leadership at multiple levels of
The Department of Biomedical and Pharmaceutical Sciences (BPS) has awarded Dr. Rachita Sumbria the 2023 BPS Paper of the Year Award. Dr. Sumbria recognition is based on her publication, “Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy.“ Dr. Sumbria’s groundbreaking research, conducted in collaboration with a
Dean Ren Ostrom recently provided his expertise in Verywell Health, a publication that reaches over 300 million readers annually. Dr. Ostrom discussed at length the implications of a recent study published in the New England Journal of Medicine regarding the necessity of beta-blockers for heart attack patients with preserved heart function. Dr. Ostrom emphasized the
Dr. Miao Zhang has been awarded a prestigious grant totaling $434,024 by the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH). This funding will support Dr. Zhang’s groundbreaking project “Channelopathy of KCa2.3 and Zimmermann-Laband syndrome,” aimed at unraveling the complexities surrounding Zimmermann-Laband syndrome 3 (ZLS3). Zimmermann-Laband syndrome 3
